Early Th2 inflammation in the upper respiratory mucosa as a predictor of severe COVID-19 and modulation by early treatment with inhaled corticosteroids: a mechanistic analysisJonathan Baker, Mona Bafadhel, Richard Russell et al.|The Lancet Respiratory Medicine|2022Cited by 58
Multidimensional prognostic risk stratification of COPD exacerbations: the baseline, acuity, and trigger (BAt) modelHnin Aung, Kristina Vermeersch, Hamish McAuley et al.|The Lancet Respiratory Medicine|2025Cited by 7
S100 Relationship of cardiac biomarkers in COPD at stable state and exacerbationPauline R.M. Dobson, REK Russell, Wollaeger Ee et al.|Unknown|2025Cited by 0
P155 Determinants of dynamic troponin rise within 30 days of moderate COPD exacerbationPauline R.M. Dobson, REK Russell, Wollaeger Ee et al.|Unknown|2025Cited by 0